Defender Capital, LLC. - Q4 2019 holdings

$113 Million is the total value of Defender Capital, LLC.'s 19 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .

 Value Shares↓ Weighting
BRKB SellBERKSHIRE HATHAWAY$25,651,000
+0.8%
113,252
-7.5%
22.78%
+0.9%
CFX SellCOLFAX CORPORATION$6,150,000
+19.2%
169,043
-4.9%
5.46%
+19.3%
WINA SellWINMARK CORPORATION$3,696,000
+8.1%
18,636
-3.9%
3.28%
+8.2%
DHR SellDANAHER CORPORATION$2,129,000
-89.4%
138,772
-0.8%
1.89%
-89.4%
INO SellINOVIO PHARMA$1,884,000
+47.3%
570,800
-8.3%
1.67%
+47.4%
AGE SellAGEX THERAPEUTICS INC$251,000
-38.3%
138,192
-32.6%
0.22%
-38.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL CL B20Q3 202324.4%
DANAHER CORPORATION COM20Q3 202318.3%
STAAR SURGICAL CORPORATION20Q3 202320.2%
FORTIVE CORPORATION20Q3 202314.3%
MONSTER BEVERAGE CORPORATION20Q3 202317.3%
APPLE INC20Q3 20230.6%
AMAZON INC COM20Q3 20230.4%
VANGUARD SHORT TERM TREASURY ETF IV17Q3 202323.9%
LINEAGE CELL THERAPEUTICS INC17Q3 20234.8%
COMPUGEN LTD ORD17Q1 20231.9%

View Defender Capital, LLC.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-06
13F-HR2024-01-23
13F-HR2023-10-23
13F-HR2023-07-18
13F-HR/A2023-05-16
13F-HR2023-04-27
13F-HR2023-01-12
13F-HR2022-10-18
13F-HR2022-07-26
13F-HR/A2022-06-07

View Defender Capital, LLC.'s complete filings history.

Compare quarters

Export Defender Capital, LLC.'s holdings